L453-0225 Screening compound: 4-[3-(2-{methyl[(2-methylphenyl)carbamoyl]amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-[3-(propan-2-yloxy)propyl]benzamide

L453-0225 Screening compound: 4-[3-(2-{methyl[(2-methylphenyl)carbamoyl]amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-[3-(propan-2-yloxy)propyl]benzamide
L453-0225 Screening compound: 4-[3-(2-{methyl[(2-methylphenyl)carbamoyl]amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-[3-(propan-2-yloxy)propyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L453-0225
4-[3-(2-{methyl[(2-methylphenyl)carbamoyl]amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-[3-(propan-2-yloxy)propyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L453-0225

Molecular Formula

C26H33N5O4 (C26 H33 N5 O4)

Compound Name

4-[3-(2-{methyl[(2-methylphenyl)carbamoyl]amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-[3-(propan-2-yloxy)propyl]benzamide

IUPAC name

4-[3-(2-{methyl[(2-methylphenyl)carbamoyl]amino}ethyl)-124-oxadiazol-5-yl]-N-[3-(propan-2-yloxy)propyl]benzamide

SMILES

CC(C)OCCCNC(c(cc1)ccc1-c1nc(CCN(C)C(Nc2c(C)cccc2)=O)no1)=O

InChI

InChI=1S/C26H33N5O4/c1-18(2)34-17-7-15-27-24(32)20-10-12-21(13-11-20)25-29-23(30-35-25)14-16-31(4)26(33)28-22-9-6-5-8-19(22)3/h5-6,8-13,18H,7,14-17H2,1-4H3,(H,27,32)(H,28,33)

InChI Key

MVVUGCQACXTSKR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27253127

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.58

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.280

Distribution Coefficient, logD

3.280

Water Solubility, LogSw

-3.49

Polar Surface Area

88.886

Acid Dissociation Constant (pKa)

13.25

Base Dissociation Constant (pKb)

0.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

L453-0225 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L453-0225 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L453-0225?
Check Price and Availability of L453-0225, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L453-0225 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L453-0225
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L453-0225
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L453-0225 available by request